HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells.

Abstract
The HGF/c-Met pathway is an important regulator of signaling pathways responsible for invasion and metastasis of most human cancers, including prostate cancer. Exposure of DU145 prostate tumor cells to HGF stimulates the PI3-kinase and MAPK pathways, leading to increased scattering, motility, and invasion, which was prevented by the addition of EGCG. EGCG acted at the level of preventing phosphorylation of tyrosines 1234/1235 in the kinase domain of the c-Met receptor without effecting dimerization. HGF-induced changes were independent of the formation of reactive oxygen species, suggesting that EGCG functioned independent of its antioxidant ability. ECG, another tea polyphenol, was as effective as EGCG, while EGC and EC were less effective. EGCG added up to 4 h after the addition of HGF still blocked cell scattering and reduced the HGF-induced phosphorylation of c-Met, Akt, and Erk, suggesting that EGCG could act both by preventing activation of c-Met by HGF and by attenuating the activity of pathways already induced by HGF. HGF did not activate the MAPK and PI3-K pathways in cells treated with methyl-beta-cyclodextrin (mCD) to remove cholesterol. Furthermore, subcellular fractionation approaches demonstrated that only phosphorylated c-Met accumulated in Triton X-100 membrane insoluble fractions, supporting a role for lipid rafts in regulating c-Met signaling. Finally, EGCG treatment inhibited DiIC16 incorporation into membrane lipid ordered domains, and cholesterol partially inhibited the EGCG effects on signaling. Together, these results suggest that green tea polyphenols with the R1 galloyl group prevent activation of the c-Met receptor by altering the structure or function of lipid rafts.
AuthorsDamian Duhon, Rebecca L H Bigelow, David T Coleman, Joshua J Steffan, Chris Yu, Will Langston, Christopher G Kevil, James A Cardelli
JournalMolecular carcinogenesis (Mol Carcinog) Vol. 49 Issue 8 Pg. 739-49 (Aug 2010) ISSN: 1098-2744 [Electronic] United States
PMID20623641 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright (c) 2010 Wiley-Liss, Inc.
Chemical References
  • Anticarcinogenic Agents
  • Antioxidants
  • Flavonoids
  • Phenols
  • Polyphenols
  • Tea
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • Catechin
  • Octoxynol
  • epicatechin gallate
  • epigallocatechin gallate
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • betadex
Topics
  • Anticarcinogenic Agents (pharmacology)
  • Antioxidants (pharmacology)
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Movement (drug effects)
  • Cells (metabolism)
  • Flavonoids (pharmacology)
  • Humans
  • Male
  • Octoxynol (metabolism, pharmacology)
  • Phenols (pharmacology)
  • Phosphatidylinositol 3-Kinases (metabolism, pharmacology)
  • Phosphorylation (drug effects)
  • Polyphenols
  • Prostatic Neoplasms (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Signal Transduction (drug effects, physiology)
  • Tea
  • beta-Cyclodextrins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: